
Sign up to save your podcasts
Or


The current standard of care is to provide a bolus of 30 mL per kg of isotonic fluid for patients with septic shock. Recent retrospective studies question this practice. Join host, Geoff Wall, as he reviewed a NEJM article on the role of fluids in septic shock.
The GameChanger
Large boluses of fluid during septic shock may have unintended adverse events. Some data show that an approach with restrictive fluids may have no difference in death or adverse outcomes.
The COVID-19 pandemic is still ‘a thing’ and the best source of protection are vaccines. The new bivalent booster vaccine provides opportunities to protect ourselves and our communities. If you, your pharmacist or technicians need Immunization Training – check out CEimpact’s VIRTUAL Administration Training. Use discount code THANKYOU to save 10%.
Show Segments
00:00 - Introductions
01:38 - Background on Septic Shock and Current Treatment
04:47 - Meyhoff et al Study
15:17 - Gamechanger: Study Findings
22:51 - Connecting to Practice
23:57 - Closing Remarks
Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
References and Resources
Redeem your CPE or CME here
Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
CE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Critique the Meyhoff et al study evaluating restrictive fluids in septic shock
2. Discuss current approaches to fluid resuscitation in patients with septic shock
0.05 CEU/0.5 Hr
UAN: 0107-0000-22-371-H01-P
Initial release date: 10/10/2022
Expiration date: 10/10/2023
Additional CPE and CME details can be found here.
Follow CEimpact on Social Media:
LinkedIn
Instagram
By CEimpact4.8
1717 ratings
The current standard of care is to provide a bolus of 30 mL per kg of isotonic fluid for patients with septic shock. Recent retrospective studies question this practice. Join host, Geoff Wall, as he reviewed a NEJM article on the role of fluids in septic shock.
The GameChanger
Large boluses of fluid during septic shock may have unintended adverse events. Some data show that an approach with restrictive fluids may have no difference in death or adverse outcomes.
The COVID-19 pandemic is still ‘a thing’ and the best source of protection are vaccines. The new bivalent booster vaccine provides opportunities to protect ourselves and our communities. If you, your pharmacist or technicians need Immunization Training – check out CEimpact’s VIRTUAL Administration Training. Use discount code THANKYOU to save 10%.
Show Segments
00:00 - Introductions
01:38 - Background on Septic Shock and Current Treatment
04:47 - Meyhoff et al Study
15:17 - Gamechanger: Study Findings
22:51 - Connecting to Practice
23:57 - Closing Remarks
Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
References and Resources
Redeem your CPE or CME here
Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
CE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Critique the Meyhoff et al study evaluating restrictive fluids in septic shock
2. Discuss current approaches to fluid resuscitation in patients with septic shock
0.05 CEU/0.5 Hr
UAN: 0107-0000-22-371-H01-P
Initial release date: 10/10/2022
Expiration date: 10/10/2023
Additional CPE and CME details can be found here.
Follow CEimpact on Social Media:
LinkedIn
Instagram

37,610 Listeners

38,878 Listeners

261 Listeners

4,803 Listeners

87,995 Listeners

3,373 Listeners

113,168 Listeners

35 Listeners

56,921 Listeners

172 Listeners

13,289 Listeners

3,761 Listeners

35 Listeners

33 Listeners

3 Listeners